Planning a Clinical Development Programme for Radiopharmaceuticals: An Analysis of International Guidelines and Expertise
INTRODUCTION. Current scientific knowledge in the field of molecular biology and the associated manufacturing and technical capabilities enable the development of radiopharmaceuticals (RPs) with high specificity to the target organs, tissues, and receptors. The development of novel RPs requires mand...
Main Authors: | D. V. Goryachev, I. V. Lysikova, A. A. Chernaia, D. D. Kushnir |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2025-02-01
|
Series: | Регуляторные исследования и экспертиза лекарственных средств |
Subjects: | |
Online Access: | https://www.vedomostincesmp.ru/jour/article/view/721 |
Similar Items
-
Radiopharmaceutical extravasations: a twenty year mini-review
by: Dustin R. Osborne
Published: (2023-07-01) -
Radiopharmaceuticals for positron emission tomography /
by: Scott, Peter J. H., et al.
Published: (c201) -
Current Status and Future Prospects of Theranostics with Radiopharmaceuticals
by: LUO Yaping, et al.
Published: (2023-07-01) -
Radioactive gold nanocluster (198-AuNCs) showed inhibitory effects on cancer cells lines
by: Shijin Xuan, et al.
Published: (2020-01-01) -
Radiopharmaceuticals : progress and clinical perspectives /
by: Fritzberg, Alan R.
Published: (1986)